BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 7691762)

  • 1. Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies.
    Hakalahti L; Vihko P; Henttu P; Autio-Harmainen H; Soini Y; Vihko R
    Int J Cancer; 1993 Oct; 55(4):590-7. PubMed ID: 7691762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in immunohistochemical staining of PSA, PAP, and TURP-27 following irradiation therapy for clinically localized prostate cancer.
    Grob BM; Schellhammer PF; Brassil DN; Wright GL
    Urology; 1994 Oct; 44(4):525-9. PubMed ID: 7524238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands.
    Abrahamsson PA; Lilja H; Falkmer S; Wadström LB
    Prostate; 1988; 12(1):39-46. PubMed ID: 2450341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the gene coding for human prostate-specific antigen and related hGK-1 in benign and malignant tumors of the human prostate.
    Henttu P; Lukkarinen O; Vihko P
    Int J Cancer; 1990 Apr; 45(4):654-60. PubMed ID: 1691151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens.
    Gallee MP; Visser-de Jong E; van der Korput JA; van der Kwast TH; ten Kate FJ; Schroeder FH; Trapman J
    Urol Res; 1990; 18(3):181-7. PubMed ID: 1697709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
    Darson MF; Pacelli A; Roche P; Rittenhouse HG; Wolfert RL; Young CY; Klee GG; Tindall DJ; Bostwick DG
    Urology; 1997 Jun; 49(6):857-62. PubMed ID: 9187691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
    Bogdanowicz JF; Bentvelsen FM; Oosterom R; Schroeder FH
    Scand J Urol Nephrol Suppl; 1991; 138():97-103. PubMed ID: 1723815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of residual tumor cells following radical radiation therapy for prostatic adenocarcinoma; immunohistochemical expression of prostate-specific antigen, prostatic acid phosphatase, and cytokeratin 8.
    Ljung G; Norberg M; Holmberg L; Busch C; Nilsson S
    Prostate; 1997 May; 31(2):91-7. PubMed ID: 9140121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
    Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M
    J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroids inversely affect the biosynthesis and secretion of human prostatic acid phosphatase and prostate-specific antigen in the LNCaP cell line.
    Henttu P; Vihko P
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):349-60. PubMed ID: 1373297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Discrepancy between the serum levels of gamma seminoprotein and prostate-specific antigen in patients with prostatic neoplasms. Both true or either untrue].
    Fujino A; Mukai N; Kawakami T; Yokoyama E; Mashimo S; Endo T; Ishibashi A; Koshiba K; Aoki Y; Itoh H
    Nihon Hinyokika Gakkai Zasshi; 1991 Apr; 82(4):541-50. PubMed ID: 1711133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression and prostate specificity of human prostatic acid phosphatase (PAP): evaluation by RNA blot analyses.
    Solin T; Kontturi M; Pohlmann R; Vihko P
    Biochim Biophys Acta; 1990 Jan; 1048(1):72-7. PubMed ID: 1688712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of prostatic acid phosphatase localization in human prostate by a monoclonal antibody with the Gleason grading system.
    Sinha AA; Gleason DF; Wilson MJ; Wick MR; Reddy PK; Blackard CE
    Prostate; 1988; 13(1):1-15. PubMed ID: 2458582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of prostatic acid phosphatase and prostate-specific antigen mRNA levels in hyperplastic prostate stimulated with steroid hormones and growth factors.
    Dulińska J; Laidler P; Labedź M
    Acta Biochim Pol; 2002; 49(2):357-68. PubMed ID: 12362977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues.
    Sharief FS; Mohler JL; Sharief Y; Li SS
    Biochem Mol Biol Int; 1994 Jun; 33(3):567-74. PubMed ID: 7524903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
    Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
    Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha 1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia.
    Björk T; Bjartell A; Abrahamsson PA; Hulkko S; di Sant'Agnese A; Lilja H
    Urology; 1994 Apr; 43(4):427-34. PubMed ID: 7512295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen as a marker of adenocarcinoma of prostate.
    Kellokumpu-Lehtinen P; Nurmi M; Koskinen P; Irjala K
    Urol Res; 1989; 17(4):245-9. PubMed ID: 2475959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.